🇺🇸 FDA
Patent

US 11903930

Methods and compositions for treatment of epileptic disorders

granted A61KA61K31/165A61K31/19

Quick answer

US patent 11903930 (Methods and compositions for treatment of epileptic disorders) held by OVID THERAPEUTICS INC. expires Mon Feb 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
OVID THERAPEUTICS INC.
Grant date
Tue Feb 20 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/165, A61K31/19, A61K31/195, A61K31/197